Multiple sclerosis (MS) is an autoimmune disease of the central nervous system,
characterized by focal inflammation, demyelination, and axonal injury. The etiology of MS is …

Brain atrophy occurs at a faster rate in patients with multiple sclerosis (MS) than in healthy
individuals. In three randomized, controlled, phase III trials, fingolimod reduced the annual …

Background Multiple sclerosis (MS) is characterized by a great inter-individual variability in
disease course and severity. Some patients experience a rather mild course, controversially …

Objective: To examine disease progression in 'aggressive'multiple sclerosis (MS), British
Columbia, Canada (1980–2009). Methods: Aggressive (or 'malignant') MS was defined as …

Background There is evidence that B cells play an important role in disease pathology of
multiple sclerosis (MS). The aim of this prospective observational study was to determine the …

Background and purpose The modifiable risk factor cigarette smoking has been associated
with an increased risk of developing multiple sclerosis (MS) and with disease activity in …

Since the first edition of Progressive Multiple Sclerosis, knowledge concerning the disease
has advanced significantly. The drive for therapies to address disease progression is active …

Glial scarring Glial scarring (sclerosis) occurs as the body attempts to repair the neuronal
cellular damage (remyelination), and in early stages of the disease this scarring can occur. 1 …

METHODS The surveillance period was 1 January 2007 through 31 December 2016. The
surveillance population included active and reserve component members of the US Army …

La esclerosis múltiple (EM) es una enfermedad desmielinizante, degenerativa y con
patogenia inmuno mediada que afecta al Sistema Nervioso Central (SNC). En su manejo …